Tazarotene

• CAT Number: A000814
• CAS Number: 118292-40-3
• Molecular Formula: C21H21NO2S
• Molecular Weight: 351.46
• Purity: ≥95%
• Synonyms: 118292-40-3; Tazorac; Zorac; Avage; Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
• Target: RARs
• Solubility: >14.9mg/mL in DMSO
• Storage: -20°C
• IUPAC Name: ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate
• InChI: InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3
• InChIKey: OGQICQVSFDPSEI-UHFFFAOYSA-N
• SMILES: CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C

Tazarotene（Cat No.:A000814）is a topical retinoid medication primarily used to treat psoriasis, acne, and photoaging. It works by modulating skin cell differentiation, proliferation, and inflammation, leading to improved skin texture and appearance. Tazarotene is effective in reducing acne lesions, decreasing psoriasis plaques, and minimizing fine wrinkles and hyperpigmentation associated with sun damage. Its unique mechanism targets retinoic acid receptors, promoting healthy skin renewal. Suitable for long-term use under medical supervision, Tazarotene offers significant therapeutic benefits in dermatology, enhancing skin health and aesthetics.